Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $716,022 - $859,966
-3,522 Reduced 55.02%
2,879 $603,000
Q2 2022

Aug 11, 2022

BUY
$174.81 - $241.14 $125,513 - $173,138
718 Added 12.63%
6,401 $1.51 Million
Q1 2022

May 12, 2022

SELL
$166.16 - $213.96 $384,328 - $494,889
-2,313 Reduced 28.93%
5,683 $1.02 Million
Q4 2021

Feb 09, 2022

SELL
$184.32 - $216.08 $480,337 - $563,104
-2,606 Reduced 24.58%
7,996 $1.73 Million
Q3 2021

Nov 10, 2021

BUY
$179.86 - $214.88 $771,419 - $921,620
4,289 Added 67.94%
10,602 $1.96 Million
Q2 2021

Aug 12, 2021

BUY
$170.47 - $211.93 $1.08 Million - $1.34 Million
6,313 New
6,313 $1.13 Million
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $257,629 - $383,876
-2,529 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $309,789 - $375,624
-3,101 Reduced 55.08%
2,529 $255,000
Q2 2020

Aug 12, 2020

SELL
$92.74 - $125.82 $409,632 - $555,746
-4,417 Reduced 43.96%
5,630 $681,000
Q1 2020

May 13, 2020

BUY
$79.39 - $115.35 $354,793 - $515,499
4,469 Added 80.12%
10,047 $953,000
Q4 2019

Feb 12, 2020

SELL
$78.31 - $95.34 $1.53 Million - $1.86 Million
-19,552 Reduced 77.8%
5,578 $491,000
Q3 2019

Nov 12, 2019

BUY
$74.85 - $85.99 $246,031 - $282,649
3,287 Added 15.05%
25,130 $2 Million
Q2 2019

Aug 12, 2019

BUY
$76.06 - $120.81 $1.24 Million - $1.97 Million
16,294 Added 293.64%
21,843 $1.71 Million
Q1 2019

May 10, 2019

BUY
$107.15 - $126.84 $594,575 - $703,835
5,549 New
5,549 $651,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.